CryoCath Technology's chief financial officer resigns

By Angela McDaniels

Seattle, Jan. 20 - CryoCath Technologies Inc. said that Steve Gannon has resigned as chief financial officer effective Feb. 24.

"My decision to leave CryoCath, while difficult, was based on the opportunity for personal growth," Gannon said in a company news release.

The company has retained an international executive recruiting firm to fill the position. In the interim, the finance and IT groups will report to director of finance, Mike Bridges.

CryoCath is a medical technology company based in Montreal that develops cryotherapy products to treat cardiovascular disease.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.